• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombolytic treatment and new calcium antagonists.

作者信息

Feely J, Pringle T, Maclean D

机构信息

St James's Hospital, Dublin.

出版信息

Br Med J (Clin Res Ed). 1988 Mar 5;296(6623):705-8. doi: 10.1136/bmj.296.6623.705.

DOI:10.1136/bmj.296.6623.705
PMID:3128377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2545310/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2d/2545310/1f2e97482418/bmj00275-0051-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2d/2545310/1f2e97482418/bmj00275-0051-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2d/2545310/1f2e97482418/bmj00275-0051-a.jpg

相似文献

1
Thrombolytic treatment and new calcium antagonists.溶栓治疗与新型钙拮抗剂。
Br Med J (Clin Res Ed). 1988 Mar 5;296(6623):705-8. doi: 10.1136/bmj.296.6623.705.
2
[Differentiated use of calcium antagonists. Current therapy of cardiovascular diseases].[钙拮抗剂的差异化应用。心血管疾病的当前治疗方法]
Internist (Berl). 1999 Oct;40(10 Suppl Moderne):1-4.
3
Coronary thrombolysis: adjuvant medical therapy.
Can J Cardiol. 1993 Jul-Aug;9(6):524-8.
4
Thrombolytic (fibrinolytic) drugs and progress in treating cardiovascular disease.
FASEB J. 2005 Apr;19(6):671.
5
Treatment of myocardial infarction in elderly patients.老年患者心肌梗死的治疗
Compr Ther. 1994;20(10):537-44.
6
[Clinical use of calcium antagonists].[钙拮抗剂的临床应用]
Duodecim. 1986;102(22):1717-24.
7
[Which therapy in the acute stage of myocardial infarct is in position to prolong survival?].
Minerva Cardioangiol. 1988 Oct;36(10):473-81.
8
Calcium antagonists for cardiovascular disease.用于治疗心血管疾病的钙拮抗剂。
Drug Ther Bull. 1993 Oct 11;31(21):81-4.
9
[Calcium blockers and their their present application].[钙阻滞剂及其目前的应用]
Przegl Lek. 1999;56(9):592-8.
10
A review of postlysis strategy.
Hosp Pract (Off Ed). 1989 Aug;24 Suppl 1:24-7; discussion 28-32. doi: 10.1080/21548331.1989.11703886.

本文引用的文献

1
Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.透壁性心肌梗死早期数小时内完全冠状动脉闭塞的发生率。
N Engl J Med. 1980 Oct 16;303(16):897-902. doi: 10.1056/NEJM198010163031601.
2
Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism.
N Engl J Med. 1980 Oct 9;303(15):842-5. doi: 10.1056/NEJM198010093031502.
3
Local low-dose thrombolytic therapy of peripheral arterial occlusions.外周动脉闭塞的局部低剂量溶栓治疗。
N Engl J Med. 1982 Dec 23;307(26):1627-30. doi: 10.1056/NEJM198212233072606.
4
Calcium antagonists, nitrates, and new antianginal drugs.钙拮抗剂、硝酸盐类药物及新型抗心绞痛药物。
Br Med J (Clin Res Ed). 1983 Apr 2;286(6371):1127-30. doi: 10.1136/bmj.286.6371.1127.
5
A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.
Circulation. 1984 Oct;70(4):606-18. doi: 10.1161/01.cir.70.4.606.
6
Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.西华盛顿州急性心肌梗死冠状动脉内链激酶随机试验。
N Engl J Med. 1983 Dec 15;309(24):1477-82. doi: 10.1056/NEJM198312153092402.
7
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.脑动脉痉挛——尼莫地平治疗蛛网膜下腔出血患者的对照试验
N Engl J Med. 1983 Mar 17;308(11):619-24. doi: 10.1056/NEJM198303173081103.
8
Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism.链激酶与肝素治疗危及生命的肺栓塞的对照临床试验比较
Br Med J. 1974 Mar 2;1(5904):343-7. doi: 10.1136/bmj.1.5904.343.
9
Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.链激酶：其临床药理学、作用机制及治疗用途综述
Drugs. 1973;5(5):357-445. doi: 10.2165/00003495-197305050-00002.
10
Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study.
Am J Surg. 1985 Oct 8;150(4A):54-63.